Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 18/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13104697 | 1.00 | PDK2 (0.35) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL26506150 | 0.95 | PDK2 (0.36) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL13104634 | 0.95 | PDK2 (0.39) | PDK2 | |
| SCHEMBL17740655 | 0.95 | PDK2 (0.39) | PDK2 | |
| SCHEMBL17780792 | 0.94 | PDK2 (0.34) | PDK2 | |
| SCHEMBL13104646 | 0.93 | PDK2 (0.40) | PDK2 | |
| SCHEMBL13104705 | 0.93 | ALDH1A1 (0.35) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL18311827 | 0.93 | PDK2 (0.39) | PDK2 | |
| SCHEMBL17180537 | 0.92 | PDK2 (0.43) | PDK2 | |
| SCHEMBL12378996 | 0.92 | PDK2 (0.39) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7807277-B2 | Amine compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2010-10-05 | — | — | US | disclosed |
| US-7807277-B2 | Amine compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2010-10-05 | — | — | US | disclosed |
| US-20080124573-A1 | AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20080124573-A1 | AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080124573-A1 | AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | AHR, HTR1D, TPH1 | PDK2 3523/4885KDM4E 1834/4885ALDH1A1 139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.